In general, the adiponectin concentration decreased in the population with metabolic risks, particularly those related to the waist-to-height index, hypoalphalipoproteinemia, and abdominal obesity, which is consistent with the literature [14,46,47]. This evidence concerns the gene ADIPOQ and hypoalphalipoproteinemia.